Next Generation Blood Testing Omnys is based on breakthrough technologies that enable high-resolution testing of blood components: Standard ABO/D typing, Phenotyping, Extended phenotyping and IAT. Omnys enables clinicians to perform multiplex testing with unmatched precision, reliability, efficiency... And minimal sample volumes! MULTIPLY LAB PRODUCTIVITY X4 ENLARGE SAMPLE CHARACTERIZATION Omnys enables a complete characterization of a blood unit with only A to 6 wells. A real productivity leap over the hands-on time and automate size reduction regarding gel card or microplates based technologies. 57% REDUCTION IN CARBON EMISSIONS Omnys dramatically reduces the amount of infectious lab waste and plastic needed to perform blood tests, as well as transportation costs. A tangible diminution of indirect costs! Move to the next-generation of blood typing and en sure maximum donor/patient compatibility with complementary data and em bedded controls at no additional cost. Omnys takes compatibility a step further and fits with regulation expectations. RESULTS EXAMPLE »»> anti-N anti-Lea anti-Leb anti-Lua anti-Lub anti-PI Expected results : B, dCEce, K+k+, Cw-, Fy(a-b+), S-s+, Jk(a+b-), M-N+, Le(a+b+), Lu(a-b+), P1+, RAI+ 1: FR240584A : Dispositif et procede de centrifugation pour la detection de microparticules dans un echantillon biologique 2 : WO2021156391: Method for capturing and identifying cellular agglutinates for detecting multiplex anti-erythrocyte antibodies Understanding life.